8-25421627-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001083111.2(GNRH1):c.183C>T(p.Phe61Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00643 in 1,606,116 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 29 hom., cov: 31)
Exomes 𝑓: 0.0058 ( 57 hom. )
Consequence
GNRH1
NM_001083111.2 synonymous
NM_001083111.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.82
Genes affected
GNRH1 (HGNC:4419): (gonadotropin releasing hormone 1) This gene encodes a preproprotein that is proteolytically processed to generate a peptide that is a member of the gonadotropin-releasing hormone (GnRH) family of peptides. Alternative splicing results in multiple transcript variants, at least one of which is secreted and then cleaved to generate gonadoliberin-1 and GnRH-associated peptide 1. Gonadoliberin-1 stimulates the release of luteinizing and follicle stimulating hormones, which are important for reproduction. Mutations in this gene are associated with hypogonadotropic hypogonadism. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 8-25421627-G-A is Benign according to our data. Variant chr8-25421627-G-A is described in ClinVar as [Benign]. Clinvar id is 788272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.82 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0129 (1960/152196) while in subpopulation AFR AF= 0.0343 (1424/41504). AF 95% confidence interval is 0.0328. There are 29 homozygotes in gnomad4. There are 933 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 29 AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNRH1 | NM_001083111.2 | c.183C>T | p.Phe61Phe | synonymous_variant | 3/4 | ENST00000421054.7 | NP_001076580.1 | |
GNRH1 | NM_000825.3 | c.195C>T | p.Phe65Phe | synonymous_variant | 2/3 | NP_000816.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNRH1 | ENST00000421054.7 | c.183C>T | p.Phe61Phe | synonymous_variant | 3/4 | 1 | NM_001083111.2 | ENSP00000391280.2 | ||
GNRH1 | ENST00000276414.4 | c.183C>T | p.Phe61Phe | synonymous_variant | 2/3 | 1 | ENSP00000276414.4 |
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1943AN: 152078Hom.: 29 Cov.: 31
GnomAD3 genomes
AF:
AC:
1943
AN:
152078
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00524 AC: 1304AN: 248810Hom.: 11 AF XY: 0.00477 AC XY: 644AN XY: 135016
GnomAD3 exomes
AF:
AC:
1304
AN:
248810
Hom.:
AF XY:
AC XY:
644
AN XY:
135016
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00575 AC: 8366AN: 1453920Hom.: 57 Cov.: 27 AF XY: 0.00555 AC XY: 4014AN XY: 723754
GnomAD4 exome
AF:
AC:
8366
AN:
1453920
Hom.:
Cov.:
27
AF XY:
AC XY:
4014
AN XY:
723754
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0129 AC: 1960AN: 152196Hom.: 29 Cov.: 31 AF XY: 0.0125 AC XY: 933AN XY: 74418
GnomAD4 genome
AF:
AC:
1960
AN:
152196
Hom.:
Cov.:
31
AF XY:
AC XY:
933
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hypogonadotropic hypogonadism 12 with or without anosmia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at